Batoclimab (also known as HBM9161 or HL161) is a fully human monoclonal antibody administered by subcutaneous injection. It works by inhibiting the neonatal fragment crystallizable receptor, which leads to a reduction in antibodies of the thyrotropin receptor.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.